TCM
GRNA

Tuttle Capital Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Tuttle Capital Management’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,942
Closed -$280K – 388
2021
Q1 		$280K Buy
+28,942
New +$284K 0.11% 194

Other funds holding GRNA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Tuttle Capital Management's GRNA Position: Q2 2021 in Review

Tuttle Capital Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2021, closing a stake of 28,942 shares — an estimated $280K sold.

Tuttle Capital Management first reported a position in GRNA in Q1 2021 and held it in 1 quarter. The position peaked at $280K in Q1 2021. 54 funds tracked by Wall St. Rank hold GRNA as of Q2 2021.

  • Tuttle Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2021 after selling out during the quarter.
  • Tuttle Capital Management sold 28,942 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2021, an estimated $280K.
  • Tuttle Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 1 quarter.
  • Tuttle Capital Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $280K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2021.

Based on Tuttle Capital Management's 13F filing for Q2 2021, filed 21 Jul 2021.